nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—ADRB3—type 2 diabetes mellitus	0.286	0.72	CbGaD
Mirabegron—CYP3A4—type 2 diabetes mellitus	0.0596	0.15	CbGaD
Mirabegron—ALB—type 2 diabetes mellitus	0.052	0.131	CbGaD
Mirabegron—ORM1—Nateglinide—type 2 diabetes mellitus	0.0388	0.0914	CbGbCtD
Mirabegron—SLCO1A2—Tolbutamide—type 2 diabetes mellitus	0.0371	0.0875	CbGbCtD
Mirabegron—BCHE—Ramipril—type 2 diabetes mellitus	0.0352	0.083	CbGbCtD
Mirabegron—ALB—Gliclazide—type 2 diabetes mellitus	0.0253	0.0597	CbGbCtD
Mirabegron—ALB—Repaglinide—type 2 diabetes mellitus	0.0238	0.0561	CbGbCtD
Mirabegron—SLCO1A2—Glyburide—type 2 diabetes mellitus	0.0213	0.0503	CbGbCtD
Mirabegron—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0199	0.0468	CbGbCtD
Mirabegron—ALB—Valsartan—type 2 diabetes mellitus	0.0175	0.0413	CbGbCtD
Mirabegron—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0175	0.0412	CbGbCtD
Mirabegron—ALB—Nateglinide—type 2 diabetes mellitus	0.0163	0.0384	CbGbCtD
Mirabegron—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0156	0.0367	CbGbCtD
Mirabegron—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0113	0.0265	CbGbCtD
Mirabegron—ALB—Glyburide—type 2 diabetes mellitus	0.011	0.026	CbGbCtD
Mirabegron—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0106	0.025	CbGbCtD
Mirabegron—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0105	0.0247	CbGbCtD
Mirabegron—ALB—Losartan—type 2 diabetes mellitus	0.0101	0.0237	CbGbCtD
Mirabegron—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00979	0.0231	CbGbCtD
Mirabegron—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00933	0.022	CbGbCtD
Mirabegron—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00853	0.0201	CbGbCtD
Mirabegron—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00804	0.0189	CbGbCtD
Mirabegron—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00773	0.0182	CbGbCtD
Mirabegron—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00771	0.0182	CbGbCtD
Mirabegron—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00746	0.0176	CbGbCtD
Mirabegron—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00674	0.0159	CbGbCtD
Mirabegron—ABCB1—Glyburide—type 2 diabetes mellitus	0.00576	0.0136	CbGbCtD
Mirabegron—ABCB1—Losartan—type 2 diabetes mellitus	0.00527	0.0124	CbGbCtD
Mirabegron—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00511	0.012	CbGbCtD
Mirabegron—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0049	0.0115	CbGbCtD
Mirabegron—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0049	0.0115	CbGbCtD
Mirabegron—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00463	0.0109	CbGbCtD
Mirabegron—ADRB3—brown adipose tissue—type 2 diabetes mellitus	0.00461	0.568	CbGeAlD
Mirabegron—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00345	0.00814	CbGbCtD
Mirabegron—CYP3A4—Losartan—type 2 diabetes mellitus	0.00316	0.00744	CbGbCtD
Mirabegron—Arbutamine—ADRB3—type 2 diabetes mellitus	0.00125	0.502	CrCbGaD
Mirabegron—Labetalol—ADRB3—type 2 diabetes mellitus	0.00089	0.356	CrCbGaD
Mirabegron—ADRB3—adipose tissue—type 2 diabetes mellitus	0.000623	0.0767	CbGeAlD
Mirabegron—SLCO1A2—kidney—type 2 diabetes mellitus	0.000282	0.0348	CbGeAlD
Mirabegron—BCHE—nephron tubule—type 2 diabetes mellitus	0.000226	0.0278	CbGeAlD
Mirabegron—Propafenone—CYP1A2—type 2 diabetes mellitus	0.000214	0.0856	CrCbGaD
Mirabegron—BCHE—cardiovascular system—type 2 diabetes mellitus	0.000203	0.025	CbGeAlD
Mirabegron—ORM1—liver—type 2 diabetes mellitus	0.000202	0.0249	CbGeAlD
Mirabegron—BCHE—adipose tissue—type 2 diabetes mellitus	0.000179	0.022	CbGeAlD
Mirabegron—SLCO1A2—liver—type 2 diabetes mellitus	0.000179	0.022	CbGeAlD
Mirabegron—ALB—liver—type 2 diabetes mellitus	0.000178	0.0219	CbGeAlD
Mirabegron—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000166	0.00145	CcSEcCtD
Mirabegron—Urinary tract infection—Losartan—type 2 diabetes mellitus	0.000164	0.00144	CcSEcCtD
Mirabegron—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000164	0.00143	CcSEcCtD
Mirabegron—Influenza—Ramipril—type 2 diabetes mellitus	0.000163	0.00142	CcSEcCtD
Mirabegron—Rhinitis—Irbesartan—type 2 diabetes mellitus	0.000162	0.00141	CcSEcCtD
Mirabegron—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.00016	0.0014	CcSEcCtD
Mirabegron—Rash—Repaglinide—type 2 diabetes mellitus	0.00016	0.0014	CcSEcCtD
Mirabegron—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00016	0.0014	CcSEcCtD
Mirabegron—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.00016	0.0014	CcSEcCtD
Mirabegron—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.00016	0.0014	CcSEcCtD
Mirabegron—Eye disorder—Metformin—type 2 diabetes mellitus	0.00016	0.0014	CcSEcCtD
Mirabegron—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.000159	0.00139	CcSEcCtD
Mirabegron—Headache—Repaglinide—type 2 diabetes mellitus	0.000159	0.00139	CcSEcCtD
Mirabegron—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000159	0.00139	CcSEcCtD
Mirabegron—Sinusitis—Losartan—type 2 diabetes mellitus	0.000159	0.00139	CcSEcCtD
Mirabegron—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.000159	0.00139	CcSEcCtD
Mirabegron—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.000158	0.00139	CcSEcCtD
Mirabegron—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000158	0.00138	CcSEcCtD
Mirabegron—Back pain—Valsartan—type 2 diabetes mellitus	0.000158	0.00138	CcSEcCtD
Mirabegron—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000157	0.00137	CcSEcCtD
Mirabegron—Back pain—Orlistat—type 2 diabetes mellitus	0.000156	0.00136	CcSEcCtD
Mirabegron—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000156	0.00136	CcSEcCtD
Mirabegron—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000156	0.00136	CcSEcCtD
Mirabegron—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000155	0.00136	CcSEcCtD
Mirabegron—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000155	0.00135	CcSEcCtD
Mirabegron—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000154	0.00135	CcSEcCtD
Mirabegron—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000154	0.00135	CcSEcCtD
Mirabegron—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000153	0.00134	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000153	0.00133	CcSEcCtD
Mirabegron—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000152	0.00133	CcSEcCtD
Mirabegron—Rhinitis—Losartan—type 2 diabetes mellitus	0.000152	0.00133	CcSEcCtD
Mirabegron—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000152	0.00133	CcSEcCtD
Mirabegron—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000151	0.00132	CcSEcCtD
Mirabegron—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000151	0.00132	CcSEcCtD
Mirabegron—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000151	0.00132	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.000151	0.00132	CcSEcCtD
Mirabegron—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000151	0.00132	CcSEcCtD
Mirabegron—Nausea—Repaglinide—type 2 diabetes mellitus	0.000151	0.00132	CcSEcCtD
Mirabegron—Asthenia—Glipizide—type 2 diabetes mellitus	0.000151	0.00132	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.00015	0.00131	CcSEcCtD
Mirabegron—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00015	0.00131	CcSEcCtD
Mirabegron—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.00015	0.00131	CcSEcCtD
Mirabegron—Pruritus—Glipizide—type 2 diabetes mellitus	0.000148	0.0013	CcSEcCtD
Mirabegron—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000148	0.00129	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000147	0.00129	CcSEcCtD
Mirabegron—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000144	0.00126	CcSEcCtD
Mirabegron—Palpitations—Valsartan—type 2 diabetes mellitus	0.000144	0.00126	CcSEcCtD
Mirabegron—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000144	0.00126	CcSEcCtD
Mirabegron—Infection—Gliclazide—type 2 diabetes mellitus	0.000144	0.00126	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000144	0.00126	CcSEcCtD
Mirabegron—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000144	0.00126	CcSEcCtD
Mirabegron—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000143	0.00125	CcSEcCtD
Mirabegron—Palpitations—Orlistat—type 2 diabetes mellitus	0.000143	0.00125	CcSEcCtD
Mirabegron—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000142	0.00125	CcSEcCtD
Mirabegron—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000142	0.00124	CcSEcCtD
Mirabegron—Propafenone—CYP3A4—type 2 diabetes mellitus	0.000142	0.0567	CrCbGaD
Mirabegron—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000142	0.00124	CcSEcCtD
Mirabegron—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000141	0.00123	CcSEcCtD
Mirabegron—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000141	0.00123	CcSEcCtD
Mirabegron—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000141	0.00123	CcSEcCtD
Mirabegron—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00014	0.00123	CcSEcCtD
Mirabegron—Vision blurred—Metformin—type 2 diabetes mellitus	0.00014	0.00123	CcSEcCtD
Mirabegron—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00014	0.00123	CcSEcCtD
Mirabegron—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00014	0.00122	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000139	0.00122	CcSEcCtD
Mirabegron—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000139	0.00122	CcSEcCtD
Mirabegron—Dizziness—Glipizide—type 2 diabetes mellitus	0.000139	0.00121	CcSEcCtD
Mirabegron—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000139	0.00121	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000138	0.00121	CcSEcCtD
Mirabegron—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000138	0.0012	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000136	0.00119	CcSEcCtD
Mirabegron—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000136	0.00119	CcSEcCtD
Mirabegron—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000136	0.00119	CcSEcCtD
Mirabegron—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000134	0.00117	CcSEcCtD
Mirabegron—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000134	0.00117	CcSEcCtD
Mirabegron—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000134	0.0165	CbGeAlD
Mirabegron—CYP3A4—kidney—type 2 diabetes mellitus	0.000134	0.0165	CbGeAlD
Mirabegron—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000134	0.00117	CcSEcCtD
Mirabegron—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000133	0.00116	CcSEcCtD
Mirabegron—Infection—Valsartan—type 2 diabetes mellitus	0.000132	0.00116	CcSEcCtD
Mirabegron—Rash—Glipizide—type 2 diabetes mellitus	0.000132	0.00116	CcSEcCtD
Mirabegron—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000132	0.00116	CcSEcCtD
Mirabegron—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000132	0.00116	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000132	0.00116	CcSEcCtD
Mirabegron—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000132	0.00116	CcSEcCtD
Mirabegron—CYP2D6—kidney—type 2 diabetes mellitus	0.000132	0.0162	CbGeAlD
Mirabegron—Headache—Glipizide—type 2 diabetes mellitus	0.000131	0.00115	CcSEcCtD
Mirabegron—Palpitations—Metformin—type 2 diabetes mellitus	0.000131	0.00115	CcSEcCtD
Mirabegron—Infection—Orlistat—type 2 diabetes mellitus	0.000131	0.00114	CcSEcCtD
Mirabegron—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00013	0.00113	CcSEcCtD
Mirabegron—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000129	0.00113	CcSEcCtD
Mirabegron—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000129	0.00113	CcSEcCtD
Mirabegron—Hypertension—Metformin—type 2 diabetes mellitus	0.000128	0.00112	CcSEcCtD
Mirabegron—Urticaria—Glyburide—type 2 diabetes mellitus	0.000128	0.00112	CcSEcCtD
Mirabegron—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000128	0.00112	CcSEcCtD
Mirabegron—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000128	0.00112	CcSEcCtD
Mirabegron—Back pain—Losartan—type 2 diabetes mellitus	0.000128	0.00112	CcSEcCtD
Mirabegron—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000128	0.00112	CcSEcCtD
Mirabegron—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000128	0.00112	CcSEcCtD
Mirabegron—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000127	0.00111	CcSEcCtD
Mirabegron—Headache—Pioglitazone—type 2 diabetes mellitus	0.000126	0.0011	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000126	0.0011	CcSEcCtD
Mirabegron—BCHE—liver—type 2 diabetes mellitus	0.000125	0.0155	CbGeAlD
Mirabegron—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000125	0.0011	CcSEcCtD
Mirabegron—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000125	0.00109	CcSEcCtD
Mirabegron—Nausea—Glipizide—type 2 diabetes mellitus	0.000125	0.00109	CcSEcCtD
Mirabegron—Vision blurred—Losartan—type 2 diabetes mellitus	0.000124	0.00109	CcSEcCtD
Mirabegron—Constipation—Gliclazide—type 2 diabetes mellitus	0.000124	0.00108	CcSEcCtD
Mirabegron—Rash—Glimepiride—type 2 diabetes mellitus	0.000123	0.00108	CcSEcCtD
Mirabegron—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000123	0.00108	CcSEcCtD
Mirabegron—Rash—Sitagliptin—type 2 diabetes mellitus	0.000123	0.00108	CcSEcCtD
Mirabegron—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000123	0.00108	CcSEcCtD
Mirabegron—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000123	0.00108	CcSEcCtD
Mirabegron—Headache—Glimepiride—type 2 diabetes mellitus	0.000123	0.00107	CcSEcCtD
Mirabegron—Headache—Sitagliptin—type 2 diabetes mellitus	0.000122	0.00107	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000121	0.00106	CcSEcCtD
Mirabegron—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000121	0.00106	CcSEcCtD
Mirabegron—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000121	0.00106	CcSEcCtD
Mirabegron—Infection—Metformin—type 2 diabetes mellitus	0.000121	0.00105	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.00012	0.00105	CcSEcCtD
Mirabegron—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000119	0.00104	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000119	0.00104	CcSEcCtD
Mirabegron—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000119	0.00104	CcSEcCtD
Mirabegron—Skin disorder—Metformin—type 2 diabetes mellitus	0.000118	0.00103	CcSEcCtD
Mirabegron—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000117	0.00103	CcSEcCtD
Mirabegron—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000117	0.00102	CcSEcCtD
Mirabegron—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000117	0.00102	CcSEcCtD
Mirabegron—Palpitations—Losartan—type 2 diabetes mellitus	0.000117	0.00102	CcSEcCtD
Mirabegron—Nausea—Glimepiride—type 2 diabetes mellitus	0.000116	0.00102	CcSEcCtD
Mirabegron—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000116	0.00101	CcSEcCtD
Mirabegron—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000116	0.00101	CcSEcCtD
Mirabegron—Asthenia—Glyburide—type 2 diabetes mellitus	0.000116	0.00101	CcSEcCtD
Mirabegron—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000115	0.00101	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000115	0.00101	CcSEcCtD
Mirabegron—Fatigue—Valsartan—type 2 diabetes mellitus	0.000115	0.001	CcSEcCtD
Mirabegron—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000115	0.001	CcSEcCtD
Mirabegron—ABCB1—retina—type 2 diabetes mellitus	0.000114	0.0141	CbGeAlD
Mirabegron—Pruritus—Glyburide—type 2 diabetes mellitus	0.000114	0.000999	CcSEcCtD
Mirabegron—Constipation—Valsartan—type 2 diabetes mellitus	0.000114	0.000997	CcSEcCtD
Mirabegron—Infection—Irbesartan—type 2 diabetes mellitus	0.000114	0.000995	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000114	0.000994	CcSEcCtD
Mirabegron—Fatigue—Orlistat—type 2 diabetes mellitus	0.000114	0.000993	CcSEcCtD
Mirabegron—Arthralgia—Losartan—type 2 diabetes mellitus	0.000112	0.000983	CcSEcCtD
Mirabegron—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000112	0.000977	CcSEcCtD
Mirabegron—Rash—Bromocriptine—type 2 diabetes mellitus	0.000111	0.000974	CcSEcCtD
Mirabegron—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000111	0.000973	CcSEcCtD
Mirabegron—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000111	0.000973	CcSEcCtD
Mirabegron—Headache—Bromocriptine—type 2 diabetes mellitus	0.000111	0.000968	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000111	0.000967	CcSEcCtD
Mirabegron—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000111	0.000967	CcSEcCtD
Mirabegron—Dry mouth—Losartan—type 2 diabetes mellitus	0.00011	0.000962	CcSEcCtD
Mirabegron—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000109	0.000953	CcSEcCtD
Mirabegron—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000108	0.0133	CbGeAlD
Mirabegron—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000108	0.000942	CcSEcCtD
Mirabegron—Infection—Losartan—type 2 diabetes mellitus	0.000107	0.000936	CcSEcCtD
Mirabegron—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000107	0.000934	CcSEcCtD
Mirabegron—Urticaria—Valsartan—type 2 diabetes mellitus	0.000106	0.000926	CcSEcCtD
Mirabegron—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000105	0.000921	CcSEcCtD
Mirabegron—Tachycardia—Losartan—type 2 diabetes mellitus	0.000105	0.00092	CcSEcCtD
Mirabegron—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000105	0.000918	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000105	0.000916	CcSEcCtD
Mirabegron—Fatigue—Metformin—type 2 diabetes mellitus	0.000105	0.000915	CcSEcCtD
Mirabegron—Urticaria—Orlistat—type 2 diabetes mellitus	0.000105	0.000915	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000104	0.000912	CcSEcCtD
Mirabegron—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000104	0.00091	CcSEcCtD
Mirabegron—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000104	0.00091	CcSEcCtD
Mirabegron—Constipation—Metformin—type 2 diabetes mellitus	0.000104	0.000908	CcSEcCtD
Mirabegron—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000103	0.000897	CcSEcCtD
Mirabegron—Rash—Glyburide—type 2 diabetes mellitus	0.000102	0.000891	CcSEcCtD
Mirabegron—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000102	0.00089	CcSEcCtD
Mirabegron—Headache—Glyburide—type 2 diabetes mellitus	0.000101	0.000885	CcSEcCtD
Mirabegron—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000101	0.000882	CcSEcCtD
Mirabegron—Palpitations—Ramipril—type 2 diabetes mellitus	0.0001	0.000875	CcSEcCtD
Mirabegron—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.92e-05	0.000868	CcSEcCtD
Mirabegron—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.92e-05	0.000868	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	9.89e-05	0.000865	CcSEcCtD
Mirabegron—Fatigue—Irbesartan—type 2 diabetes mellitus	9.87e-05	0.000863	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	9.82e-05	0.000859	CcSEcCtD
Mirabegron—Constipation—Irbesartan—type 2 diabetes mellitus	9.79e-05	0.000856	CcSEcCtD
Mirabegron—ABCB1—cardiovascular system—type 2 diabetes mellitus	9.67e-05	0.0119	CbGeAlD
Mirabegron—Urticaria—Metformin—type 2 diabetes mellitus	9.64e-05	0.000843	CcSEcCtD
Mirabegron—Arthralgia—Ramipril—type 2 diabetes mellitus	9.64e-05	0.000843	CcSEcCtD
Mirabegron—Nausea—Glyburide—type 2 diabetes mellitus	9.59e-05	0.000839	CcSEcCtD
Mirabegron—Abdominal pain—Metformin—type 2 diabetes mellitus	9.59e-05	0.000839	CcSEcCtD
Mirabegron—Dizziness—Gliclazide—type 2 diabetes mellitus	9.59e-05	0.000839	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	9.57e-05	0.000837	CcSEcCtD
Mirabegron—Asthenia—Valsartan—type 2 diabetes mellitus	9.56e-05	0.000836	CcSEcCtD
Mirabegron—Dyspepsia—Losartan—type 2 diabetes mellitus	9.49e-05	0.00083	CcSEcCtD
Mirabegron—ABCB1—kidney—type 2 diabetes mellitus	9.46e-05	0.0117	CbGeAlD
Mirabegron—Asthenia—Orlistat—type 2 diabetes mellitus	9.45e-05	0.000826	CcSEcCtD
Mirabegron—Pruritus—Valsartan—type 2 diabetes mellitus	9.43e-05	0.000825	CcSEcCtD
Mirabegron—Dry mouth—Ramipril—type 2 diabetes mellitus	9.43e-05	0.000825	CcSEcCtD
Mirabegron—ABCB1—pancreas—type 2 diabetes mellitus	9.4e-05	0.0116	CbGeAlD
Mirabegron—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	9.36e-05	0.000819	CcSEcCtD
Mirabegron—Pruritus—Orlistat—type 2 diabetes mellitus	9.32e-05	0.000815	CcSEcCtD
Mirabegron—Fatigue—Losartan—type 2 diabetes mellitus	9.29e-05	0.000813	CcSEcCtD
Mirabegron—Constipation—Losartan—type 2 diabetes mellitus	9.22e-05	0.000806	CcSEcCtD
Mirabegron—ABCB1—cortex of kidney—type 2 diabetes mellitus	9.22e-05	0.0113	CbGeAlD
Mirabegron—Rash—Gliclazide—type 2 diabetes mellitus	9.15e-05	0.0008	CcSEcCtD
Mirabegron—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.14e-05	0.000799	CcSEcCtD
Mirabegron—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.12e-05	0.000797	CcSEcCtD
Mirabegron—Urticaria—Irbesartan—type 2 diabetes mellitus	9.1e-05	0.000796	CcSEcCtD
Mirabegron—Headache—Gliclazide—type 2 diabetes mellitus	9.09e-05	0.000795	CcSEcCtD
Mirabegron—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.05e-05	0.000792	CcSEcCtD
Mirabegron—Tachycardia—Ramipril—type 2 diabetes mellitus	9.02e-05	0.000789	CcSEcCtD
Mirabegron—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.01e-05	0.000788	CcSEcCtD
Mirabegron—Skin disorder—Ramipril—type 2 diabetes mellitus	8.98e-05	0.000785	CcSEcCtD
Mirabegron—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.81e-05	0.000771	CcSEcCtD
Mirabegron—Dizziness—Valsartan—type 2 diabetes mellitus	8.81e-05	0.000771	CcSEcCtD
Mirabegron—Dizziness—Orlistat—type 2 diabetes mellitus	8.71e-05	0.000762	CcSEcCtD
Mirabegron—Asthenia—Metformin—type 2 diabetes mellitus	8.71e-05	0.000761	CcSEcCtD
Mirabegron—Nausea—Gliclazide—type 2 diabetes mellitus	8.62e-05	0.000753	CcSEcCtD
Mirabegron—Pruritus—Metformin—type 2 diabetes mellitus	8.59e-05	0.000751	CcSEcCtD
Mirabegron—Urticaria—Losartan—type 2 diabetes mellitus	8.56e-05	0.000749	CcSEcCtD
Mirabegron—ABCB1—adipose tissue—type 2 diabetes mellitus	8.53e-05	0.0105	CbGeAlD
Mirabegron—Abdominal pain—Losartan—type 2 diabetes mellitus	8.52e-05	0.000745	CcSEcCtD
Mirabegron—CYP3A4—liver—type 2 diabetes mellitus	8.45e-05	0.0104	CbGeAlD
Mirabegron—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	8.42e-05	0.000736	CcSEcCtD
Mirabegron—Rash—Valsartan—type 2 diabetes mellitus	8.4e-05	0.000735	CcSEcCtD
Mirabegron—Dermatitis—Valsartan—type 2 diabetes mellitus	8.39e-05	0.000734	CcSEcCtD
Mirabegron—Headache—Valsartan—type 2 diabetes mellitus	8.35e-05	0.00073	CcSEcCtD
Mirabegron—CYP2D6—liver—type 2 diabetes mellitus	8.31e-05	0.0102	CbGeAlD
Mirabegron—Diarrhoea—Metformin—type 2 diabetes mellitus	8.3e-05	0.000726	CcSEcCtD
Mirabegron—Rash—Orlistat—type 2 diabetes mellitus	8.3e-05	0.000726	CcSEcCtD
Mirabegron—Dermatitis—Orlistat—type 2 diabetes mellitus	8.29e-05	0.000725	CcSEcCtD
Mirabegron—Headache—Orlistat—type 2 diabetes mellitus	8.25e-05	0.000721	CcSEcCtD
Mirabegron—Asthenia—Irbesartan—type 2 diabetes mellitus	8.22e-05	0.000719	CcSEcCtD
Mirabegron—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.13e-05	0.000711	CcSEcCtD
Mirabegron—Pruritus—Irbesartan—type 2 diabetes mellitus	8.1e-05	0.000709	CcSEcCtD
Mirabegron—Dizziness—Metformin—type 2 diabetes mellitus	8.02e-05	0.000702	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.98e-05	0.000698	CcSEcCtD
Mirabegron—Fatigue—Ramipril—type 2 diabetes mellitus	7.97e-05	0.000697	CcSEcCtD
Mirabegron—Nausea—Valsartan—type 2 diabetes mellitus	7.92e-05	0.000692	CcSEcCtD
Mirabegron—Constipation—Ramipril—type 2 diabetes mellitus	7.9e-05	0.000691	CcSEcCtD
Mirabegron—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.84e-05	0.000685	CcSEcCtD
Mirabegron—Nausea—Orlistat—type 2 diabetes mellitus	7.82e-05	0.000684	CcSEcCtD
Mirabegron—Asthenia—Losartan—type 2 diabetes mellitus	7.73e-05	0.000676	CcSEcCtD
Mirabegron—Rash—Metformin—type 2 diabetes mellitus	7.65e-05	0.000669	CcSEcCtD
Mirabegron—Dermatitis—Metformin—type 2 diabetes mellitus	7.64e-05	0.000669	CcSEcCtD
Mirabegron—Pruritus—Losartan—type 2 diabetes mellitus	7.62e-05	0.000667	CcSEcCtD
Mirabegron—Headache—Metformin—type 2 diabetes mellitus	7.6e-05	0.000665	CcSEcCtD
Mirabegron—Dizziness—Irbesartan—type 2 diabetes mellitus	7.57e-05	0.000662	CcSEcCtD
Mirabegron—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.56e-05	0.000661	CcSEcCtD
Mirabegron—Diarrhoea—Losartan—type 2 diabetes mellitus	7.37e-05	0.000645	CcSEcCtD
Mirabegron—Urticaria—Ramipril—type 2 diabetes mellitus	7.34e-05	0.000642	CcSEcCtD
Mirabegron—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.31e-05	0.000639	CcSEcCtD
Mirabegron—Rash—Irbesartan—type 2 diabetes mellitus	7.22e-05	0.000631	CcSEcCtD
Mirabegron—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.21e-05	0.000631	CcSEcCtD
Mirabegron—Nausea—Metformin—type 2 diabetes mellitus	7.21e-05	0.00063	CcSEcCtD
Mirabegron—Headache—Irbesartan—type 2 diabetes mellitus	7.17e-05	0.000627	CcSEcCtD
Mirabegron—Dizziness—Losartan—type 2 diabetes mellitus	7.13e-05	0.000623	CcSEcCtD
Mirabegron—Nausea—Irbesartan—type 2 diabetes mellitus	6.8e-05	0.000595	CcSEcCtD
Mirabegron—Rash—Losartan—type 2 diabetes mellitus	6.8e-05	0.000594	CcSEcCtD
Mirabegron—Dermatitis—Losartan—type 2 diabetes mellitus	6.79e-05	0.000594	CcSEcCtD
Mirabegron—Headache—Losartan—type 2 diabetes mellitus	6.75e-05	0.00059	CcSEcCtD
Mirabegron—Asthenia—Ramipril—type 2 diabetes mellitus	6.63e-05	0.00058	CcSEcCtD
Mirabegron—Pruritus—Ramipril—type 2 diabetes mellitus	6.54e-05	0.000572	CcSEcCtD
Mirabegron—Nausea—Losartan—type 2 diabetes mellitus	6.4e-05	0.00056	CcSEcCtD
Mirabegron—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.32e-05	0.000553	CcSEcCtD
Mirabegron—Dizziness—Ramipril—type 2 diabetes mellitus	6.11e-05	0.000534	CcSEcCtD
Mirabegron—ABCB1—liver—type 2 diabetes mellitus	5.98e-05	0.00737	CbGeAlD
Mirabegron—Rash—Ramipril—type 2 diabetes mellitus	5.83e-05	0.00051	CcSEcCtD
Mirabegron—Dermatitis—Ramipril—type 2 diabetes mellitus	5.82e-05	0.000509	CcSEcCtD
Mirabegron—Headache—Ramipril—type 2 diabetes mellitus	5.79e-05	0.000506	CcSEcCtD
Mirabegron—Nausea—Ramipril—type 2 diabetes mellitus	5.49e-05	0.00048	CcSEcCtD
Mirabegron—ADRB3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.12e-06	0.000115	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	6.1e-06	0.000115	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	6.09e-06	0.000115	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	6.06e-06	0.000114	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—MTHFR—type 2 diabetes mellitus	6.04e-06	0.000114	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	6.02e-06	0.000114	CbGpPWpGaD
Mirabegron—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	5.98e-06	0.000113	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PPARA—type 2 diabetes mellitus	5.93e-06	0.000112	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CETP—type 2 diabetes mellitus	5.91e-06	0.000112	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	5.91e-06	0.000112	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	5.91e-06	0.000112	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.84e-06	0.00011	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	5.79e-06	0.000109	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	5.79e-06	0.000109	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	5.79e-06	0.000109	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	5.76e-06	0.000109	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—AGT—type 2 diabetes mellitus	5.74e-06	0.000108	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	5.67e-06	0.000107	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CALM1—type 2 diabetes mellitus	5.65e-06	0.000107	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—APOE—type 2 diabetes mellitus	5.63e-06	0.000106	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	5.62e-06	0.000106	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PPARG—type 2 diabetes mellitus	5.58e-06	0.000105	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.57e-06	0.000105	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.57e-06	0.000105	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—APOA1—type 2 diabetes mellitus	5.56e-06	0.000105	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	5.51e-06	0.000104	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	5.51e-06	0.000104	CbGpPWpGaD
Mirabegron—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	5.49e-06	0.000104	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	5.49e-06	0.000104	CbGpPWpGaD
Mirabegron—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	5.49e-06	0.000104	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	5.49e-06	0.000104	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	5.49e-06	0.000104	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	5.49e-06	0.000104	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—INS—type 2 diabetes mellitus	5.48e-06	0.000103	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	5.4e-06	0.000102	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CTGF—type 2 diabetes mellitus	5.39e-06	0.000102	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	5.37e-06	0.000101	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	5.37e-06	0.000101	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	5.37e-06	0.000101	CbGpPWpGaD
Mirabegron—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	5.34e-06	0.000101	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	5.33e-06	0.000101	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	5.3e-06	0.0001	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.27e-06	9.95e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	5.26e-06	9.94e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	5.26e-06	9.94e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—RELA—type 2 diabetes mellitus	5.24e-06	9.9e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	5.24e-06	9.89e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	5.23e-06	9.87e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	5.19e-06	9.8e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	5.19e-06	9.8e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	5.18e-06	9.77e-05	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	5.16e-06	9.75e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	5.09e-06	9.61e-05	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	5.08e-06	9.6e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	5.07e-06	9.57e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	5.07e-06	9.57e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	5.06e-06	9.55e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	5.06e-06	9.55e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	5.06e-06	9.55e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	5.03e-06	9.49e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	5.02e-06	9.49e-05	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ALB—type 2 diabetes mellitus	5.02e-06	9.48e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	4.98e-06	9.4e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	4.97e-06	9.38e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	4.97e-06	9.38e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	4.94e-06	9.32e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PPARG—type 2 diabetes mellitus	4.9e-06	9.25e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	4.89e-06	9.24e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	4.89e-06	9.24e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	4.89e-06	9.24e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	4.88e-06	9.21e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	4.84e-06	9.15e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.82e-06	9.1e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	4.81e-06	9.09e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	4.81e-06	9.09e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	4.81e-06	9.09e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—INS—type 2 diabetes mellitus	4.81e-06	9.07e-05	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—NOS3—type 2 diabetes mellitus	4.8e-06	9.07e-05	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	4.8e-06	9.07e-05	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.77e-06	9.02e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GCG—type 2 diabetes mellitus	4.76e-06	8.99e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	4.76e-06	8.99e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.73e-06	8.93e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	4.72e-06	8.92e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.7e-06	8.87e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	4.68e-06	8.84e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	4.6e-06	8.69e-05	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.59e-06	8.67e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	4.58e-06	8.65e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	4.54e-06	8.56e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	4.54e-06	8.56e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	4.54e-06	8.56e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.47e-06	8.44e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	4.45e-06	8.41e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.42e-06	8.35e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	4.41e-06	8.33e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ALB—type 2 diabetes mellitus	4.41e-06	8.32e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	4.4e-06	8.31e-05	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PTGS2—type 2 diabetes mellitus	4.39e-06	8.29e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.35e-06	8.22e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.35e-06	8.22e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.34e-06	8.19e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	4.32e-06	8.15e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.31e-06	8.14e-05	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—SRC—type 2 diabetes mellitus	4.28e-06	8.08e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.24e-06	8.01e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—NOS3—type 2 diabetes mellitus	4.21e-06	7.96e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PIK3R1—type 2 diabetes mellitus	4.21e-06	7.96e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	4.17e-06	7.88e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	4.17e-06	7.88e-05	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	4.17e-06	7.87e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.16e-06	7.86e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.16e-06	7.86e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.16e-06	7.86e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.16e-06	7.86e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	4.15e-06	7.83e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—SRC—type 2 diabetes mellitus	4.12e-06	7.78e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.1e-06	7.75e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GNB3—type 2 diabetes mellitus	4.1e-06	7.75e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	4.1e-06	7.74e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	4.1e-06	7.74e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	4.09e-06	7.72e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CAT—type 2 diabetes mellitus	4.03e-06	7.61e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.01e-06	7.58e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	4e-06	7.55e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.99e-06	7.53e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	3.93e-06	7.42e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	3.93e-06	7.42e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—APOB—type 2 diabetes mellitus	3.91e-06	7.39e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PTGS2—type 2 diabetes mellitus	3.85e-06	7.28e-05	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	3.83e-06	7.23e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	3.81e-06	7.19e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—LPL—type 2 diabetes mellitus	3.74e-06	7.06e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.71e-06	7e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.68e-06	6.96e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	3.66e-06	6.91e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GPX1—type 2 diabetes mellitus	3.65e-06	6.88e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.61e-06	6.82e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	3.6e-06	6.79e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.6e-06	6.79e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	3.58e-06	6.76e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CD36—type 2 diabetes mellitus	3.55e-06	6.7e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	3.53e-06	6.67e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	3.51e-06	6.62e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.46e-06	6.54e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.43e-06	6.48e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.39e-06	6.41e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.39e-06	6.41e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.39e-06	6.4e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.39e-06	6.4e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.37e-06	6.37e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	3.36e-06	6.35e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.34e-06	6.3e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.33e-06	6.29e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.33e-06	6.28e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.31e-06	6.24e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.31e-06	6.24e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.31e-06	6.24e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PPARA—type 2 diabetes mellitus	3.3e-06	6.23e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.29e-06	6.2e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.27e-06	6.18e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.23e-06	6.1e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.23e-06	6.09e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	3.21e-06	6.05e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—AGT—type 2 diabetes mellitus	3.2e-06	6.04e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	3.19e-06	6.03e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.19e-06	6.02e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CALM1—type 2 diabetes mellitus	3.14e-06	5.94e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	3.14e-06	5.94e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—APOE—type 2 diabetes mellitus	3.13e-06	5.91e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	3.11e-06	5.87e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—APOA1—type 2 diabetes mellitus	3.1e-06	5.85e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.09e-06	5.83e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.07e-06	5.8e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.02e-06	5.7e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.01e-06	5.68e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.97e-06	5.6e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.97e-06	5.6e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.97e-06	5.6e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	2.95e-06	5.57e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.93e-06	5.54e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.91e-06	5.5e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.9e-06	5.47e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.89e-06	5.46e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.88e-06	5.45e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.82e-06	5.33e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	2.8e-06	5.29e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.78e-06	5.25e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.78e-06	5.24e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.75e-06	5.2e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.74e-06	5.18e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PPARG—type 2 diabetes mellitus	2.73e-06	5.15e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.73e-06	5.15e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.71e-06	5.12e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.71e-06	5.12e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.68e-06	5.06e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.68e-06	5.06e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—INS—type 2 diabetes mellitus	2.68e-06	5.05e-05	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	2.66e-06	5.02e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.64e-06	4.98e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.6e-06	4.9e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.59e-06	4.88e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.57e-06	4.85e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.57e-06	4.85e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.56e-06	4.84e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.56e-06	4.83e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.39e-06	4.51e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	2.35e-06	4.43e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—NOS3—type 2 diabetes mellitus	2.35e-06	4.43e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.34e-06	4.43e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.25e-06	4.25e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.22e-06	4.18e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.22e-06	4.18e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.21e-06	4.17e-05	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—AKT1—type 2 diabetes mellitus	2.21e-06	4.17e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.21e-06	4.16e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.18e-06	4.11e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.15e-06	4.06e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	2.15e-06	4.05e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.11e-06	3.99e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.06e-06	3.88e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.06e-06	3.88e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.06e-06	3.88e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.03e-06	3.82e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.02e-06	3.81e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.97e-06	3.73e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.97e-06	3.72e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.94e-06	3.66e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.94e-06	3.66e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—AKT1—type 2 diabetes mellitus	1.94e-06	3.66e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.92e-06	3.62e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.89e-06	3.57e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.88e-06	3.55e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.82e-06	3.43e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.78e-06	3.36e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.77e-06	3.35e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.73e-06	3.26e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.7e-06	3.2e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.69e-06	3.19e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.67e-06	3.16e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.47e-06	2.78e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.44e-06	2.73e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.32e-06	2.5e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.27e-06	2.39e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.27e-06	2.39e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.16e-06	2.19e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	2.04e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	9.45e-07	1.78e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	8.91e-07	1.68e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.82e-07	1.1e-05	CbGpPWpGaD
